Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

Over Long Term, Yoga Trumps Usual Care for Improving Back Function in Patients Suffering from Low Back Pain In the largest and longest study of its kind published to date, more than 300 patients were followed for one year. Chronic or recurrent back pain cost the U.S. health care system billions of dollars each year, and is one of the most common reasons people visit their doctor…

 

Relievant Medsystems, Inc. announced the company has received Food and Drug Administration approval of an Investigational Device Exemption (IDE) to begin their SMART pivotal trial to evaluate the safety and effectiveness of the Intracept® System for treatment of chronic low back pain…

 

Results from an ongoing prospective study report that a novel spinal neuromodulation device changes the paradigm for patients suffering with low back pain who have not found relief through conventional spinal cord stimulation (SCS). The single-centered results from this ongoing, multi-centered study were presented at the American Academy of Pain Medicine’s 27th Annual Meeting…

 

iTech Medical, Inc. (OTCBB:IMSU)(FWB:0IM), a medical information technology company, announced that it has received Health Canada approval for the Company’s Muscle Pattern Recognition (MPR) System, a non-invasive clinical assessment tool being developed to assist in the diagnosis and treatment of back and neck pain, one of the most common chronic conditions in Canada…

 

Interventional Spine, Inc. announced the completion of another successful surgery with the unique PERPOS Percutaneous Cervical System for the treatment of neck pain. To the Company’s knowledge, the PERPOS Percutaneous Cervical System is the only product that can stabilize the posterior cervical spine with a truly percutaneous procedure…

 

Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world’s first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs…

 

Slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as $10,000 per patient, new Johns Hopkins-led research suggests…

 

A new technology that revolutionizes the way low back pain is diagnosed and treated, while also significantly reducing healthcare costs, has been introduced by SpineMatrix(R) Inc., an Akron, Ohio-based medical technology company that specializes in advanced spinal diagnostics. SpineMatrix’s new, non-invasive Lumbar Matrix(TM) Scan uses high-speed computer processing of thousands of bioelectric signals to observe neuromuscular activity of the low back.




February 2012
Mon Tue Wed Thu Fri Sat Sun
« Jan    
 12345
6789101112
13141516171819
20212223242526
272829